Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02119026
Brief Title: Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer (PASSION)

First Submitted : April 1, 2014
First Submitted that Met QC Criteria : April 18, 2014
First Posted : April 21, 2014 (Estimate)

Results First Submitted : May 5, 2019
Results First Submitted that Met QC Criteria : September 23, 2019
Results First Posted : September 25, 2019

Last Update Submitted that Met QC Criteria : September 23, 2019
Last Update Posted : September 25, 2019